UAE - Prime Hospital announced that the paper submitted on its unique experience in Antibiotics Stewardship Program (ASP) has been accepted to be presented at the upcoming European Conference of Clinical Microbiology and Infectious Diseases (ECCMID 2019), which is set to take place in Amsterdam, Netherlands, from April 13-16 this year. The event is a leading global event in the field of clinical microbiology and infectious diseases, which will bring together 12,000 participants this year.
The paper titled "Effectiveness of retrospective audit and feedback by utilizing hospital informatics as part of Antibiotic Stewardship Program on Ceftriaxone and fluoroquinolones consumption in the emergency department of a 100-bed private hospital in Dubai, UAE" has been authored by Dr. Dirar Abdallah, Consultant Internal Medicine, Head of ICU and Chair of ASP Program at Prime Hospital and a member of the UAE National ASP Committee, in collaboration with the emergency and IT departments.
The paper describes monitoring and effective reduction of the usage of certain classes of antibiotics called Ceftriaxone and Fluoroquinolones. If abused/overused/misused without clear indication, both these classes can lead to the development of resistant bacteria, which is emerging as a major global healthcare challenge causing deaths, morbidities and prolonged hospitalization, among many other hazards.
Dr. Jamil Ahmed, Managing Director of Prime Healthcare Group said: “The ASP at Prime Hospital is designed to regulate the overuse of antibiotics, which can lead to resistant bacteria. The tool was developed through our electronic medical records (EMR) to monitor the use of all antibiotics in our hospital, with a special focus on above mentioned two categories of antibiotics prescribed by our emergency department physicians. We then educated our physicians to concentrate on prescribing the antibiotic only if indicated and to choose the right antibiotics according to the hospital’s approved clinical best practice guidelines. These measures resulted in a dramatic 50-70 per cent decrease in the use of these antibiotics. We are confident that this significant reduction will have a positive impact on rate of resistant bacteria in the near future.”
-Ends-
For further information, please contact:
Orient Planet PR & Marketing Communications
P.O. Box: 500266
Dubai, United Arab Emirates
Tel: 00971 4 4562888
Email : media@orientplanet.com
Website: www.orientplanet.com
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
